Transforming Brain Cancer Care

Every brain cancer patient is unique, and so is every brain tumor.

Neuro-oncology teams need new tools and insights to advance the state of care.

At Neosoma, our mission is to help clinicians improve outcomes by providing novel disease insights to physicians and clinical trials through innovative AI technology.

Brain Tumors Are Complex

Every Treatment Decision is Based on MRI Interpretation

Care is a multi-disciplinary process with significant limitations to treatment.​​

The Answers Are Hidden Within Every MRI

Critical data that is needed to improve treatment and outcomes exists inside every slice of each MRI.

Without Advanced AI Technology, These Insights will Never Be Accessed

Even the most expert clinicians are forced to use subjective judgement when assessing a brain tumor MRI.

Neosoma Uncovers Transformative Disease Insights
from Brain Tumor MRIs

Down-Curve Background - Purple.png

Comprehensive Neuro-Oncology
SaaS Solution

Proprietary, Patent-Pending

AI-Powered 3-D Tumor Analysis

Longitudinal Disease Assessment

Centralized Document Management

Virtual Tumor Board Sessions

Barco Monitor with Tumor Board Screenshot.png

Patient Notes,

Auditing,

Session Attendance

Researcher Icon.png

Neuro-Radiologist

Neurosurgeon Icon.png

Neuro-Surgeon

Neuroradiologist Icon.png

Neuro-Oncologist

Neuro-Oncologist Icon.png

Radiation Oncologist

Researcher Icon.png

Medical Oncologist

A unified, clinican-validated software platform for the entire neuro-oncology team, combining tumor board workflow with multiple disease-specific AI-driven analysis modules.​

 

Seamless Integration; Deep Insights

Routinely-Acquired MRI Sequences
Brats_ANG_1_T1_Pre_094.png
Brats_ANG_1_T1_Post_094.png
Brats_ANG_1_T2_094.png
Brats_ANG_1_Flair_094.png

T1-pre

T1-post

T2

FLAIR

NeoSoma Logo - Isolated.png
Disease Analysis Engine:
Extracting Hidden Insights
Brats_ANG_1_T1_Post_094.png
High-grade glioma segmentation
Multiple, Disease-Specific
Neosoma
Analysis Modules
Patient Management Platform:
Centralized Decisioning
Barco Monitor with Tumor Board Screenshot.png
Longitudinal
Disease Insights
Interoperability with
Existing Systems
Centralized
Decisioning Platform

Neosoma Benefits Clinicians, Hospitals,
Patients, and Clinical Trials

Neosoma Dashboard - Tumor Board

Clinicians and Hospitals

We enable better clinical decisions, thereby raising the standard of care.

Hospitals drive increased patient volume and revenue, while reducing unnecessary costs.

Patients

Increased engagement with your physicians, better understanding of your disease and treatment protocol, and greater confidence in tumor change and response to treatment.

3-D Tumor with Skull - Side View.png

Clinical Trials

Increase success and efficiency of clinical research and development through greater speed, accuracy, precision, and consistency of key endpoints, including RANO.

Neosoma High-Grade Glioma Response Assessment (RANO)
 

See An Interactive Example Of A
High-Grade Glioma Segmentation

Use mouse wheel to scroll through slices.
Brats_ANG_1_T1_Post_094.png
Brats_ANG_1_RSeg_094.png
Current slice: 
Up-Curve Background - Purple.png

In Clinicians' Own Words

landolfi-joseph-1033119383.jpg
“Neosoma avoids interruptions in care, unnecessary surgeries, and unnecessary changes in therapy.  The entire team benefits from centralized information, more efficient communication, and treatment protocols tailored to each specific patient.”

Joseph Landolfi, D.O.

Chief Medical Officer, JFK Hackensack Meridian Health

 

In Collaboration with Leading Clinical Sites

UCLA_H_2019_RGB.png
UF-Health-email-signature-logo.png
JFK Hackensack Logo - Transparent.png
Methodist-logo-300x194.png

Clinicians.  Entrepreneurs.  Scientists.
We're Passionate About What We Do.

Staff Meeting

Research and Publications

Transform Your Neuro-Oncology Practice

Scientist using microscope

Interested in Exploring A Collaboration?

Please reach out!